Iodine
DERMATOLOGICALS
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Iodine is a drug catalogued in DrugCentral. Recorded indications include CD20 Positive Non-Hodgkin's Lymphoma and Provision of therapeutic radionuclide.
- Indications: CD20 Positive Non-Hodgkin's Lymphoma and Provision of therapeutic radionuclide.
- ATC code: D08AG01 (Iodine products).
- Molecular formula: I2; molecular weight 253.81 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (2)
- CD20 Positive Non-Hodgkin's Lymphoma
- Provision of therapeutic radionuclide
Off-label uses (7)
- Hyperthyroidism
- Iodine deficiency
- Lymphocutaneous sporotrichosis
- Neonatal thyrotoxicosis
- Thyroid Gland Radiation Protection
- Thyroid Surgery
- Thyrotoxic crisis
Contraindications (20)
- Bacterial septicemia
- Breastfeeding (mother)
- Bronchitis
- Decreased respiratory function
- Denuded skin
- Disease of liver
- Hashimoto thyroiditis
- Heart block
- Human Anti-Mouse Antibody (HAMA) Positive
- Hypocomplementemic urticarial vasculitis
- Hypothyroidism
- Kidney disease
- Neutropenic disorder
- Open wound
- Pregnancy, function
- Pulmonary tuberculosis
- Seizure disorder
- Severe Bone Marrow Depression
- Shock
- Thrombocytopenic disorder
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
D08AG01 | DERMATOLOGICALS › ANTISEPTICS AND DISINFECTANTS › ANTISEPTICS AND DISINFECTANTS › Iodine products |
D08AG03 | DERMATOLOGICALS › ANTISEPTICS AND DISINFECTANTS › ANTISEPTICS AND DISINFECTANTS › Iodine products |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Drug hypersensitivity | 1179.5 |
| Amaurosis fugax | 337.0 |
| Ocular discomfort | 284.9 |
| Haemorrhagic stroke | 280.8 |
| Head discomfort | 231.0 |
| Urinary tract disorder | 227.3 |
| Blindness | 183.9 |
| Eye pain | 163.8 |
| Photophobia | 156.6 |
| Generalised oedema | 156.4 |
| Haematemesis | 150.9 |
| Altered state of consciousness | 147.1 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Iodine is on its molecule page.
| Molecular formula | I2 |
|---|---|
| Molecular weight | 253.81 g/mol |
| CAS number | — |
| InChIKey | PNDPGZBMCMUPRI-UHFFFAOYSA-N |
| PubChem CID | 807 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Iodine used for?
DrugCentral lists the following indications for Iodine: CD20 Positive Non-Hodgkin's Lymphoma and Provision of therapeutic radionuclide.
What is the chemical formula of Iodine?
Iodine has the molecular formula I2 and a molecular weight of 253.81 g/mol.
Browse: all drugs starting with I · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 4446 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1201225 — compound record and bioactivity
- PubChem CID 807 — chemical identifiers
- DrugBank DB05382 — drug record
- FDA UNII 9679TC07X4 — substance identity
- DailyMed: FDA labels for Iodine — current prescribing information (label search)
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.